IMNM Immunome, Inc.
Immunome, Inc. (IMNM) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $2.3M.
Where they traded
Last open-market purchase: June 5, 2026 , by BIENAIME JEAN JACQUES .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Barchas Isaac | Director | Sell 10b5-1 | 11,048 | $27.25 | $301.1K | 92,211 −10.7% of holding | |
| Barchas Isaac | Director | Sell 10b5-1 | 62,291 | $26.23 | $1.6M | None left | |
| Barchas Isaac | Director | Sell 10b5-1 | 10,125 | $26.07 | $264.0K | 62,291 −14% of holding | |
| Barchas Isaac | Director | Sell 10b5-1 | 15,248 | $26.06 | $397.4K | 72,416 −17.4% of holding | |
| Barchas Isaac | Director | Sell 10b5-1 | 20,840 | $26.06 | $543.1K | 87,664 −19.2% of holding | |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 90,616 | $25.09 | $2.3M | None left | |
| Barchas Isaac | Director | Sell 10b5-1 | 16,906 | $24.20 | $409.1K | 108,504 −13.5% of holding | |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 1,092 | $25.00 | $27.3K | None left | |
| Barchas Isaac | Director | Sell 10b5-1 | 83,094 | $24.11 | $2.0M | 125,410 −39.9% of holding | |
| Barchas Isaac 2 fills | Director | Sell 10b5-1 | 100,000 | $22.59 | $2.3M | 232,839 −30% of holding | |
| Lechleider Robert 3 fills | Chief Medical Officer | Sell 10b5-1 | 55,000 | $22.62 | $1.2M | 48,091 −53.4% of holding | |
| Barchas Isaac | Director | Sell 10b5-1 | 101,050 | $21.12 | $2.1M | 308,504 −24.7% of holding | |
| Lechleider Robert 2 fills | Chief Medical Officer | Sell 10b5-1 | 55,000 | $19.85 | $1.1M | 30,225 −64.5% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.